Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q1 2024 Q4 2023
Period Ending Mar 31, 2025 Mar 31, 2024 Dec 31, 2023
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-16.38M -6.03M -3.46M
Interest Income
n/a n/a n/a
Pretax Income
-17.07M -6.88M -3.47M
Net Income
-17.07M -6.88M -3.47M
Selling & General & Admin
5.42M 1.1M 498K
Research & Development
10.96M 4.93M 2.97M
Other Expenses
n/a n/a n/a
Operating Expenses
16.38M 6.03M 3.46M
Interest Expense
1.56M 117K 39K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
16.38M 6.03M 3.46M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
4.05M 18.7M n/a
Shares Outstanding (Diluted)
4.05M 18.7M n/a
EPS (Basic)
-2.7 -0.18 n/a
EPS (Diluted)
-2.7 -0.18 n/a
EBITDA
-15.51M -6.76M -3.43M
EBIT
-15.51M -6.76M -3.43M
Depreciation & Amortization
n/a n/a n/a